Search - tctmd.com

Displaying 161 - 180 of 539

Sort: Relevancy | Date

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

L.A. McKeown

October 24, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Shelley Wood

September 28, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

Advertisement

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Many STEMI Patients Not Treated Within National Time Goals

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

November 2022 News Roundup

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

New Biomarker-Based Risk Score Performs Well in ACS

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

October 2022 News Roundup

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content